Aggregation-induced emission-active iridium (III)-based mitochondria-targeting nanoparticle for two-photon imaging-guided photodynamic therapy

Xucan Yang,Lulu Cheng,Yile Zhao,Haoran Ma,Haitao Song,Xuanmin Yang,Kang-Nan Wang,Yanrong Zhang

DOI: https://doi.org/10.1016/j.jcis.2023.12.172

IF: 9.9

2023-12-01

Journal of Colloid and Interface Science

Abstract:The efficacy of imaging-guided photodynamic therapy (PDT) is compromised by the attenuation of fluorescence and decline in reactive oxygen species (ROS) generation efficiency in the physiological environment of conventional photosensitizers, limited near-infrared (NIR) absorption, and high systemic cytotoxicity. This paper presents the synthesis of two cyclometalated Ir (III) complexes (Ir-thpy and Ir-ppy) by using a triphenylamine derivative (DPTPA) as the primary ligand and their encapsulation into an amphiphilic phospholipid to form nanoparticles (NPs). These complexes exhibit aggregation-induced emission features and remarkably enhanced ROS generation compared to Chlorin e6 (Ce6). Moreover, Ir-thpy NPs possess the unique ability to selectively target mitochondria, leading to depolarization of the mitochondrial membrane potential and ultimately triggering apoptosis. Notably, Ir-thpy NPs exhibit exceptional photocytotoxicity even towards cisplatin-resistant A549/DDP tumor cells. In vivo two-photon imaging verified the robust tumor-targeting efficacy of Ir-thpy NPs. The in vivo results unequivocally demonstrate that Ir-thpy NPs exhibit excellent tumor ablation along with remarkable biocompatibility. This study presents a promising approach for the development of multifunctional Ir-NPs for two-photon imaging-guided PDT and provides novel insights for potential clinical applications in oncology.

chemistry, physical

What problem does this paper attempt to address?

This paper aims to solve several key problems in photodynamic therapy (PDT) for tumor treatment:

1. **Fluorescence attenuation and decreased reactive oxygen species generation efficiency**: In the physiological environment, the fluorescence signal of traditional photosensitizers will be weakened, and at the same time, the generation efficiency of reactive oxygen species (ROS) will also decrease, which affects the efficacy of PDT.
2. **Limited near - infrared absorption**: Traditional photosensitizers have limited absorption capacity in the near - infrared (NIR) region, resulting in poor activation effect in deep tissues.
3. **High systemic toxicity**: Traditional photosensitizers may have high systemic toxicity, which limits their clinical application.

To overcome these problems, the authors designed and synthesized two iridium(III) - based cyclometalated complexes (Ir - thpy and Ir - ppy), and encapsulated them into nanoparticles (NPs) by amphiphilic phospholipids. These complexes have aggregation - induced emission (AIE) characteristics and show significantly enhanced ROS generation ability in aqueous solution, which is superior to the commercial chlorin e6 (Ce6).

In addition, Ir - thpy NPs have the ability to selectively target mitochondria, can cause depolarization of the mitochondrial membrane potential, and finally trigger apoptosis. In particular, Ir - thpy NPs also show high photocytotoxicity against cisplatin - resistant A549/DDP tumor cells.

The strong tumor - targeting ability of Ir - thpy NPs was verified by in vivo two - photon imaging. The experimental results show that Ir - thpy NPs can not only efficiently eliminate tumors, but also have good biocompatibility. This study provides new ideas for the development of multifunctional two - photon imaging - guided PDT and has potential clinical application prospects.